IGF system and peripheral arterial disease: Relationship with disease severity and inflammatory status of the affected limb

Clinical Endocrinology

Volumn 69, Issue 6, 2008, Pages 894-900

  Brevetti, Gregorio ^a,b   Colao, Annamaria ^b   Schiano, Vittorio ^b   Pivonello, Rosario ^b   Laurenzano, Eugenio ^b   Di Somma, Carolina ^b   Lombardi, Gaetano ^b   Chiariello, Massimo ^b  

^a University of Naples 'Federico II' ^*  (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; AORTA; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMORAL VEIN; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ANKLE BRACHIAL INDEX; C-REACTIVE PROTEIN; CARRIER PROTEINS; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES;

EID: 55949108771     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03269.x     Document Type: Article

References (43)

1. Rosen, C.J. Pollak, M. (1999) Circulating IGF-I. New perspectives for a new century. Trends in Endocrinology and Metabolism, 10, 136 141.
2. Bornfeldt, K.E., Raines, E.W., Nakano, T., Graves, L.M., Krebs, E.G. Ross, R. (1994) Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. Journal of Clinical Investigations, 93, 1266 1274.
3. Bennett, M.R., Evan, G.I. Schwartz, S.M. (1995) Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. Journal of Clinical Investigations, 95, 2266 2274.
4. Tsukahara, H., Gordienko, D.V., Tonshoff, B., Gelato, M.C. Goligorsky, M.S. (1994) Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney International, 45, 598 604.
5. Muniyappa, R., Walsh, M.F., Rangi, J.S., Zayas, R.M., Standley, P.R., Ram, J.L. Sowers, J.R. (1997) Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Science, 61, 925 931.
6. Conn, K.J., Rich, C.B., Jensen, D.E., Fontanilla, M.R., Bashir, M.M., Rosenbloom, J. Foster, J.A. (1996) Insulin-like growth factor-I regulates transcription of the elastin gene through a putative retinoblastoma control element. A role for Sp3 acting as a repressor of elastin gene transcription. Journal of Biological Chemistry, 271, 28853 28860.
7. Kaplan, R.C., Strickler, H.D., Rohan, T.E., Muzumdar, R. Brown, D.L. (2005) Insulin-like growth factors and coronary heart disease. Cardiology in Review, 13, 35 39.
8. Janssen, J.A., Stolk, R.P., Pols, H.A., Grobbee, D.E., de Jong, F.H. Lamberts, S.W. (1998) Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clinical Endocrinology, 48, 471 478.
9. Reeves, I., Abribat, T., Laramee, P., Jasmin, G. Brazeau, P. (2000) Age-related serum levels of insulin like growth factor-I-II and IGF-binding protein-3 following myocardial infarction. Growth Hormone and IGF Research, 10, 78 84.
10. Spallarossa, P., Brunelli, C., Minuto, F., Caruso, D., Battistini, M., Caponnetto, S. Cordera, R. (1996) Insulin-like growth factor-I and angiographically documented coronary artery disease. American Journal of Cardiology, 77, 200 202.
11. Schuler-Luttmann, S., Monnig, G., Enbergs, A., Schulte, H., Breithardt, G., Assmann, G., Kerber, S. von Eckardstein, A. (2000) Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology, 20, E10 E15.
12. Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J. Jorgensen, T. (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation, 106, 939 944.
13. Laughlin, G.A., Barrett-Connor, E., Criqui, M.H. Kritz-Silverstein, D. (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism, 89, 114 120.
14. Schwab, S., Spranger, M., Krempien, S., Hacke, W. Bettendorf, M. (1997) Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. Stroke, 28, 1744 1748.
15. van den Beld, A.W., Bots, M.L., Janssen, J.A., Pols, H.A., Lamberts, S.W. Grobbee, D.E. (2003) Endogenous hormones and carotid atherosclerosis in elderly men. American Journal of Epidemiology, 157, 25 31.
16. Denti, L., Annoni, V., Cattadori, E., Salvagnini, M.A., Visioli, S., Merli, M.F., Corradi, F., Ceresini, G., Valenti, G., Hoffman, A.R. Ceda, G.P. (2004) Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. American Journal of Medicine, 117, 312 317.
17. Creager, M.A., Jones, D.W., Easton, J.D., Halperin, J.L., Hirsch, A.T., Matsumoto, A.H., O'Gara, P.T., Safian, R.D., Schwartz, G.L., Spittell, J.A. American Heart Association (2004) Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapy. Circulation, 109, 2634 2642.
18. Gardner, A.W. (2002) Sex differences in claudication pain in subjects with peripheral arterial disease. Medicine and Science in Sports and Exercise, 34, 1695 1698.
19. Eliakim, A., Brasel, J.A., Mohan, S., Wong, W.L. Cooper, D.M. (1998) Increased physical activity and the growth hormone-IGF-I axis in adolescent males. American Journal of Physiology, 275, R308 R314.
20. Lanfranco, F., Gianotti, L., Giordano, R., Pellegrino, M., Maccario, M. Arvat, E. (2003) Ageing, growth hormone and physical performance. Journal of Endocrinological Investigations, 26, 861 872.
21. Okura, Y., Brink, M., Zahid, A.A., Anwar, A. Delafontaine, P. (2001) Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. Journal of Molecular and Cellular Cardiology, 33, 1777 1789.
22. Patel, V.A., Zhang, Q.J., Siddle, K., Soos, M.A., Goddard, M., Weissberg, P.L. Bennett, M.R. (2001) Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circulation Research, 88, 895 902.
23. Bennett, M.R., Evan, G.I. Schwartz, S.M. (2002) Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and - independent pathways. Circulation Research, 77, 266 273.
24. Libby, P. Aikawa, M. (2002) Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nature Medicine, 8, 1257 1262.
25. Ruberg, F.L., Leopold, J.A. Loscalzo, J. (2002) Atherothrombosis: plaque instability and thrombogenesis. Progress in Cardiovascular Disease, 44, 381 394.
26. Scheidegger, K.J., James, R.W. Delafontaine, P. (2000) Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells. Journal of Biological Chemistry, 275, 26864 26869.
27. Neuberg, M., Buckbinder, L., Seizinger, B. Kley, N. (1997) The p53/IGF-1 receptor axis in the regulation of programmed cell death. Endocrine, 7, 107 109.
28. Cox, D.R. (1972) Regression and life tables. Journal of the Royal Statistical Society, Series B, 34, 187 220.
29. Libby, P., Ridker, P.M. Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 1135 1143.
30. Brevetti, G., Piscione, F., Silvestro, A., Galasso, G., Di Donato, A., Oliva, G., Scopacasa, F. Chiariello, M. (2003) Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thrombosis and Haemostasis, 89, 1058 1063.
31. Tataru, M.C., Heinrich, J., Junker, R., Schulte, H., von Eckardstein, A., Assmann, G. Koehler, E. (2000) C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. European Heart Journal, 21, 1000 1008.
32. Anwar, A., Zahid, A.A., Scheidegger, K.J., Brink, M. Delafontaine, P. (2002) Tumor necrosis factor-α regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation, 105, 1220 1225.
33. Jia, G., Cheng, G., Soundararajan, K. Agrawal, D.K. (2007) Insulin-like growth factor-1 receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: effect of IL-12 and IFN-γ. American Journal of Physiology - Heart and Circulatory Physiology, 292, H1051 H1057.
34. Silha, J.V., Gui, Y., Modric, T., Suwanichkul, A., Durham, S.K., Powell, D.R. Murphy, L.J. (2001) Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice. Endocrinology, 142, 4305 4313.
35. Kaplan, R.C., McGinn, A.P., Pollak, M.N., Kuller, L.H., Strickler, H.D., Rohan, T.E., Cappola, A.R., Xue, X. Psaty, B.M. (2007) Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. Journal of Clinical Endocrinology and Metabolism, 92, 1319 1325.
36. McDermott, M.M., Greenland, P., Liu, K., Guralnik, J.M., Celic, L., Criqui, M.H., Chan, C., Martin, G.J., Schneider, J., Pearce, W.H., Taylor, L.M. Clark, E. (2002) The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Annals of Internal Medicine, 136, 873 883.
37. Collet-Solberg, P.F. Cohen, P. (1996) The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF actions. Endocrinology and Metabolism Clinics of North America, 25, 591 614.
38. Delafontaine, P., Song, Y.H. Li, Y. (2004) Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 435 444.
39. Arnqvist, H.J., Bornfeldt, K.E., Chen, Y. Lindstrom, T. (1995) The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism, 44, 58 66.
40. Wickman, A., Jonsdottir, I.H., Bergstrom, G. Hedin, L. (2002) GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. European Journal of Endocrinology, 147, 523 533.
41. Pasterkamp, G., Schoneveld, A.H., van der Wal, A.C., Hijnen, D.J., van Wolveren, W.J., Plomp, S., Teepen, H.L. Borst, C. (1999) Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 54 58.
42. Vainas, T., Stassen, F.R., de Graaf, R., Twiss, E.L., Herngreen, S.B., Welten, R.J., van den Akker, L.H., van Dieijen-Visser, M.P., Bruggeman, C.A. Kitslaar, P.J. (2005) C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. Journal of Vascular Surgery, 42, 243 251.
43. Granata, R., Trovato, L., Garbarino, G., Taliano, M., Ponti, R., Sala, G., Ghidoni, R. Ghigo, E. (2004) Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways. FASEB Journal, 18, 1456 1458.